Skip to main content

Table 1 Correlation between mitochondrial superoxide dismutase (SOD2) expression and clinicopathological characteristics in 61 endometriosis-associated ovarian cancers

From: Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers

Characteristic Cases, n SOD2 expression, n P value
High (n = 46) Low (n = 15)
Age, years
 60< 11 10 1 0.2646
 ≤ 60 50 36 14  
FIGO class
 Low (I, II) 51 38 13 0.9999
 High (III, IV) 10 8 2  
Blood marker
 Positive 48 37 11 0.7175
 Negative 13 9 4  
Histology
 Clear cell 41 33 8 0.2164
 Endometrioid 20 13 7  
Treatment
 Complete 53 41 12 0.3934
 Incomplete 8 5 3  
  1. Patients were stratified according to mitochondrial superoxide dismutase (SOD2) expression. SOD2 expression was not associated with age, International Federation of Gynecology and Obstetrics (FIGO) stage, blood markers, histology, or completeness of adjuvant primary treatment